AEMD - Aethlon Medical Corp Trailing Twelve Months Revenue Growth

Aethlon Medical relies on local US suppliers to ensure a stable flow of filter cartridges. The company plans to generate revenue through the implementation of the Hemopurifier blood purification system. The YoY revenue growth rate over a rolling 12-month period demonstrates the fundamental development vector, with the indicator currently standing at 0.00. Business success is based on clinical results and the receipt of insurance reimbursements.
aethlonmedical.com (AEMD) - metric breakdowns and financial figures

Professional asset selection is based on identifying stable organic business expansion, which eliminates speculative noise. By analyzing the current YoY revenue growth rate on a TTM basis, the investor observes trailing twelve-month dynamics confirming the commercial implementation of the Hemopurifier technology and its integration into treatment protocols for resistant infections, transforming the technological potential of Aethlon Medical (AEMD) into actual cash flows.